Mario Petretta
Overview
Explore the profile of Mario Petretta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
1692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nappi C, Megna R, Zampella E, Volpe F, Piscopo L, Falzarano M, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39994020
Purpose: We performed an external validation of a predictive model for persistent/metastatic disease in patients with differentiated thyroid cancer (DTC) at post-treatment I whole-body scintigraphy (WBS). Methods: Our study population...
2.
Zampella E, Assante R, DAntonio A, Mannarino T, Gaudieri V, Nappi C, et al.
Circ Cardiovasc Imaging
. 2024 Nov;
17(11):e016815.
PMID: 39508096
Background: Coronary flow capacity (CFC) is a measure that integrates hyperemic myocardial blood flow and myocardial flow reserve to quantify the pathophysiological impact of coronary artery disease on vasodilator capacity....
3.
Nappi C, Ponsiglione A, Vallone C, Lepre R, Basile L, Green R, et al.
J Cardiovasc Dev Dis
. 2024 Oct;
11(10).
PMID: 39452301
Whole-body positron emission tomography (PET)-computed tomography (CT) imaging performed for oncological purposes may provide additional parameters such as the coronary artery calcium (CAC) and epicardial adipose tissue (EAT) volume with...
4.
5.
Megna R, Petretta M, Nappi C, Assante R, Zampella E, Gaudieri V, et al.
Front Nucl Med
. 2024 Oct;
4:1232135.
PMID: 39355219
Introduction: Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) are non-invasive nuclear medicine techniques that can identify areas of abnormal myocardial perfusion. We assessed the prevalence of cardiovascular...
6.
Petretta M, Nappi C, Cuocolo A
Front Nucl Med
. 2024 Oct;
3:1342672.
PMID: 39355025
No abstract available.
7.
Santomauro M, Petretta M, Riganti C, Santomauro M, De Luca M, Santomauro A, et al.
Monaldi Arch Chest Dis
. 2024 Sep;
PMID: 39221677
Subcutaneous implantable cardioverter-defibrillators (S-ICD) are effective in protecting patients against sudden death but expose them to a higher risk of inappropriate shock (IAS). We performed a systematic search of studies...
8.
Assante R, Zampella E, DAntonio A, Mannarino T, Gaudieri V, Nappi C, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jan;
51(6):1612-1621.
PMID: 38191816
Purpose: We evaluated the impact on cardiovascular outcome of coronary revascularization-induced changes in ischemic total perfusion defect (ITPD) and myocardial flow reserve (MFR) as assessed by Rb positron emission tomography...
9.
Petretta A, Cuocolo A, Petretta M
Am J Cardiol
. 2023 Dec;
212:137-138.
PMID: 38101463
No abstract available.
10.
Maurea S, Verde F, Romeo V, Stanzione A, Mainenti P, Raia G, et al.
Eur J Radiol
. 2023 Oct;
168:111116.
PMID: 37801998
Purpose: To build and validate a predictive model of placental accreta spectrum (PAS) in patients with placenta previa (PP) combining clinical risk factors (CRF) with US and MRI signs. Method:...